Spokane startup Gestalt Diagnostics raises $7.5M to advance AI-enabled cancer detection
Spokane-based startup Gestalt Diagnostics announced it has raised $7.5 million to enhance its artificial intelligence tools for digital pathology analysis.
The new funding will support efforts to reach more customers, improve the tool’s AI capabilities and accelerate the process of obtaining clearance from the Food and Drug Administration. “We’ve already streamlined how pathologists navigate fragmented systems by creating PathFlow, a unified platform for viewing pathology cases digitally and collaborating with leading experts in real-time without the need to ship specimens,” said Gestalt CEO Dan Roark in a statement. “Now, we’ll accelerate innovation and scale our reach to meet the growing demands of modern pathology.”
With this new funding, Gestalt will strengthen Spokane’s emerging life sciences hub, which is home to 57 biotech companies, according to a recent report from Life Science Washington.